0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Neurology
Editorial  | 
Is Apolipoprotein E Required for Cognitive Function in Humans?  Implications for Alzheimer Drug Development
Courtney Lane-Donovan, SB; Joachim Herz, MD
JAMA Neurology
Editorial  | 
Secondary Prevention Trials in Alzheimer Disease:  The Challenge of Identifying a Meaningful End Point
Richard J. Kryscio, PhD
JAMA Neurology
Original Investigation  | 
The Preclinical Alzheimer Cognitive Composite:  Measuring Amyloid-Related Decline
Michael C. Donohue, PhD; Reisa A. Sperling, MD; David P. Salmon, PhD; et al.
JAMA Neurology
Original Investigation  | 
Effect of 1 Night of Total Sleep Deprivation on Cerebrospinal Fluid β-Amyloid 42 in Healthy Middle-Aged Men:  A Randomized Clinical Trial
Sharon Ooms, MSc; Sebastiaan Overeem, MD; Kees Besse, MD; et al.